These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 18646118)

  • 41. Heroin maintenance for chronic heroin dependents.
    Ferri M; Davoli M; Perucci CA
    Cochrane Database Syst Rev; 2003; (3):CD003410. PubMed ID: 12917967
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Alpha2-adrenergic agonists for the management of opioid withdrawal.
    Gowing L; Farrell MF; Ali R; White JM
    Cochrane Database Syst Rev; 2014 Mar; (3):CD002024. PubMed ID: 24683051
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Buprenorphine for the management of opioid withdrawal.
    Gowing L; Ali R; White J
    Cochrane Database Syst Rev; 2006 Apr; (2):CD002025. PubMed ID: 16625553
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Opioid antagonists under heavy sedation or anaesthesia for opioid withdrawal.
    Gowing L; Ali R; White J
    Cochrane Database Syst Rev; 2006 Apr; (2):CD002022. PubMed ID: 16625552
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Pharmacological interventions for drug-using offenders.
    Perry AE; Neilson M; Martyn-St James M; Glanville JM; McCool R; Duffy S; Godfrey C; Hewitt C
    Cochrane Database Syst Rev; 2013 Dec; (12):CD010862. PubMed ID: 24353217
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Oral naltrexone maintenance treatment for opioid dependence.
    Minozzi S; Amato L; Vecchi S; Davoli M; Kirchmayer U; Verster A
    Cochrane Database Syst Rev; 2011 Feb; (2):CD001333. PubMed ID: 21328250
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Systematic reviews of the effectiveness of day care for people with severe mental disorders: (1) acute day hospital versus admission; (2) vocational rehabilitation; (3) day hospital versus outpatient care.
    Marshall M; Crowther R; Almaraz-Serrano A; Creed F; Sledge W; Kluiter H; Roberts C; Hill E; Wiersma D; Bond GR; Huxley P; Tyrer P
    Health Technol Assess; 2001; 5(21):1-75. PubMed ID: 11532238
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Oral naltrexone maintenance treatment for opioid dependence.
    Minozzi S; Amato L; Vecchi S; Davoli M; Kirchmayer U; Verster A
    Cochrane Database Syst Rev; 2011 Apr; 2011(4):CD001333. PubMed ID: 21491383
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Heroin maintenance for chronic heroin-dependent individuals.
    Ferri M; Davoli M; Perucci CA
    Cochrane Database Syst Rev; 2011 Dec; 2011(12):CD003410. PubMed ID: 22161378
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Opiate treatment for opiate withdrawal in newborn infants.
    Osborn DA; Jeffery HE; Cole M
    Cochrane Database Syst Rev; 2005 Jul; (3):CD002059. PubMed ID: 16034871
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Buprenorphine for the management of opioid withdrawal.
    Gowing L; Ali R; White JM
    Cochrane Database Syst Rev; 2009 Jul; (3):CD002025. PubMed ID: 19588330
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Opioid antagonists for alcohol dependence.
    Srisurapanont M; Jarusuraisin N
    Cochrane Database Syst Rev; 2005 Jan; (1):CD001867. PubMed ID: 15674887
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Methadone maintenance at different dosages for opioid dependence.
    Faggiano F; Vigna-Taglianti F; Versino E; Lemma P
    Cochrane Database Syst Rev; 2003; (3):CD002208. PubMed ID: 12917925
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Psychosocial combined with methadone maintenance treatments versus methadone maintenance treatments alone for treatment of opioid use disorder: A meta-analysis.
    Liu C; Li Y
    J Addict Dis; 2024; 42(2):126-135. PubMed ID: 36607171
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Opiate treatment for opiate withdrawal in newborn infants.
    Osborn DA; Cole MJ; Jeffery HE
    Cochrane Database Syst Rev; 2002; (3):CD002059. PubMed ID: 12137642
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Buprenorphine for the management of opioid withdrawal.
    Gowing L; Ali R; White J
    Cochrane Database Syst Rev; 2004 Oct; (4):CD002025. PubMed ID: 15495026
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Pharmacological therapies for maintenance treatments of opium dependence.
    Rahimi-Movaghar A; Amin-Esmaeili M; Hefazi M; Yousefi-Nooraie R
    Cochrane Database Syst Rev; 2013 Jan; (1):CD007775. PubMed ID: 23440817
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Opioid antagonists with minimal sedation for opioid withdrawal.
    Gowing L; Ali R; White J
    Cochrane Database Syst Rev; 2006 Jan; (1):CD002021. PubMed ID: 16437438
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A comparison of methadone, buprenorphine and alpha(2) adrenergic agonists for opioid detoxification: a mixed treatment comparison meta-analysis.
    Meader N
    Drug Alcohol Depend; 2010 Apr; 108(1-2):110-4. PubMed ID: 20074867
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Buprenorphine for the management of opioid withdrawal.
    Gowing L; Ali R; White J
    Cochrane Database Syst Rev; 2000; (3):CD002025. PubMed ID: 10908521
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.